Editorial: The PRIME trial establishes biparametric MRI as a viable alternative to multiparametric MRI for prostate cancer diagnosis, offering reduced time, cost, and invasiveness.

ja.ma/4m9lkAk

In a trial of men with suspected prostate cancer, biparametric MRI, which excludes the gadolinium contrast sequence, was noninferior to multiparametric MRI for detecting clinically significant cases.

ja.ma/4nnwliq

Can integrating MRI into #ProstateCancer screening reduce unnecessary biopsies?

An international team including TRANSFORM researchers @londonprostate1.bsky.social, Prof Shonit Punwani, and Prof Anwar Padhani review the evidence in @euplatinum.bsky.social

Grab a ☕ and read: doi.org/10.1016/j.eu...

DOI:10.1001/jamaoncol.2025.1594

-MRI-screening reduces unnecessary Bx.
-Aggressive PCa detection increase with MRI.
-Overdiagnosis of insign PCa drops
-Benefit/harm improves with each screening round.
-MRI sustains efficiency+safety over repeated rounds.
-Fewer Bx’s in subsequent screening rounds.

I am inviting everyone interested in high resolution ultrasound / Micro ultrasound to join the interactive session on the AIS channel next Wednesday!

www.aischannel.com/coffee-with/...

Most viewed in the last 7 days from JAMA: In this trial, microultrasonography-guided biopsy was noninferior to MRI-guided fusion biopsy for the detection of clinically significant prostate cancer.

https://ja.ma/4iOClPk

Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial

jamanetwork.com/journals/jam...

These findings suggest that microultrasonography could serve as an alternative to MRI for prostate cancer diagnosis.
#ProstateCancer

Finally out! Micro US is non inferior to MRI. A novel tool for prostate cancer diagnostics

Micro-ultrasonography-guided biopsy is noninferior to MRI-guided fusion biopsy for the detection of clinically significant prostate cancer in biopsy naïve men. https://ja.ma/4hvl4cr #EAU25

Who else is getting excited for the upcoming EAU congress in Madrid @uroweb.bsky.social ?
Prof Klotz will present the Optimum Study on high res micro Us vs MRI for prostate cancer diagnosis. Will it be a game changer ? @londonprostate1.bsky.social @dr-coops.bsky.social

Finally out! Our new paper @ JAMAOncology MRI pathway for men at risk for prostate cancer
•🧠 593 participants, 48% negative MRI
•🔍 261 avoided biopsy, 41% over 3 years
Proposal of how to follow MRI negative men! #MRI #ProstateCancer jamanetwork.com/journals/jam...